Interested as paying attention to the results of P1. Yes. Insterested in funding BMSN prior to P1. Not so much but you never know.

Results so far are animal based. Big Pharma would only come a calling if P1 results in humans show 1)it's safe and well tolerated in the individuals receiving the treatment and 2) BP feels it can work with the company/management.

That's what we don't know as I stated in a previous post. We still don't know a lick about how koos will deal with the big wigs at a BP. BPs don't bend over for little upstarts.